1 |
Andersen, P. H., Gr nvald, F. C. and Jansen, J. A. (1985). A comparison between dopaminestimulatcd adenylcyclase and -SCH 23390 binding in rat striatum. Life Sci, 37, 1971-1975
DOI
ScienceOn
|
2 |
Andersen, P. H. and Jandsen, J. A. (1990). Dopamine receptor agonists: Selectivity and dopamine D, receptor efficacy. Eur. J. Pharmacol, 188, 335-341
DOI
ScienceOn
|
3 |
Arnt, J., Hyttel, J. and Sanchez, C. (1992). Partial and full dopamine D, receptor agonists in mice and rats: relation bctween behavioural effects and stimulation of adenylate cydase activily in vitro. Eur. J. Pharmacol., 213, 259-26
DOI
ScienceOn
|
4 |
Ashworth, R., Lote, C. J., Thewles, A. and Wood, J. A. (1989). Increased renal papillary solute concentration in response to atrial natriuretic factor (ANF) infusion in rats.J. Physiol., 417, 167-173
|
5 |
Bello-Reuss, E., Pastoriza-Munoz, E. and Colinders, R. E. (1977). Acute unilateral renal denervation in rats with extracellular volume expansion. Am. J. Physiol., 232(1), F26-F32
|
6 |
Borne, R. M. (1952). Hemodynamics and sodiurn excretion of denervated kidney in anethetized and unanethethized dog. Am. J. Physiol., 171, 14-158
|
7 |
Elsa, B. R., Rumulo, E. C., Enrique, P. M., Robert, A. M. and Carl, W. G. (1975). Effects of acute unilateral renal denervation in the rat. J. Clin. Invest., 56, 208-212
DOI
|
8 |
Goldberg, L. I, (1972). Cardiovascular and renal actions of dopamine: Potential clinical applications. Pannacot- Rev., 24, 1-29
|
9 |
Green, R. (1990). Renal actions of atiral natriuretic factor. In: Atrial natriuretic factor edited by A. D. Struthers. Blackwell Scientic publications, Oxford 0X2 OEL, pp. 89-113
|
10 |
Kebabian, J. W. and Calne, D. B. (1979). Multiple receptors for dopamine. Nature, 277, 93-96
DOI
ScienceOn
|
11 |
고석태. (1971). 닭의 신장 기능에 미치는 oxytocin의 영향. 약제학회지, 1, 34-36
|
12 |
고석태 · 정경희. (2001). Dopamine D, Receptor 효능제인 SKF 81297의 신장작용. 응용약물학회지 , 9, 209-217
|
13 |
고석태 ·유강준·황명성. (1998). Nitric oxide의 합성 억제제인 -Nitro-L-Arginine 의 신장작용. 약학회지, 5, 519-526
|
14 |
고석태 ·강호연. (1984).개의 신내 혈류에 미치는 dopamine 의 영항. 약학회지, 28, 149-160
|
15 |
고석태 · 나한광 · 최인. (1996). 5-Hydoxytryptamine(5-HT)이 개의 신장 기능에 미치는 영향. 응용약물학회지, 1, 7-18
|
16 |
고석태 ·박화숙. (1990). Arachidonic acid가 개의 신장 기능 에 미치는 영향. 약학회지, 34, 252-261
|
17 |
Nomura, G., Tababtake, T., Arai, S., Unv., D., Shimao, M. and Hattori, N. (1977). Effect of acute unilateral renal denervation on tubular reabsoiption in dog. Am. J. Physiol., 232, F16-F19
|
18 |
Phillips, B. A. (1994). Quantitative Clinical Chemistry, Vol. 2, Methods, edited by peters and van Slyke, William & Wilkins
|
19 |
Andersen, P. H., Nielsen, E. B., Gr envald, F. C. and Braestrup, C. (1986). Some atypical neuroleptics inhibit [ ] SCH 23390 bing in vivo. Eur. J .Pharmacol., 120, 143-147
DOI
ScienceOn
|
20 |
Arnt, J., Bogeso, K. P., Hyttel, J. and Meier, E. (1988a). Relative dopamine D, and receptor affinity and efficacy determine whether dopamine agonist induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol., 62, 121-126
|
21 |
Smith, H. W., Finkelstein, N., Aliminosa, L., Crawford, B. and Graber, B. (1945). The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J. Clin. Invest., 21, 388-404
|
22 |
Snedecor, G. W., and Cochran, W. G. (1980). Statistical Methods, 7th ed. lowa State Univ
|
23 |
Vidal, M. J., Romero, J. C. and Vanhoutte, P. M. (1998). Eneothelium-derived relaxing factor inhibits renin release. Eurr. J. Pharmacol., 149, 401-402
|
24 |
Stein, J. H., Congbalay, R. I., Karsh, D. U., Osgood, R. W. and Ferries, T. F. (1972). The effects of bradykinin on proxymal tubular sodium reabsorption in dog: Evidence for functional nephron heterogeneity. J. C1in. Invest., 51, 1709-1717
DOI
|
25 |
Stein, J. H, Reineck, J. H., Osgood, R. W. and Ferries, T. F. Effect of acetylcholinc on proxymal tubular sodium reabsoiption in the dog. Am. J. Physiol., 220, 227-235
|
26 |
Stoof, J. C. and Kebabian, J. W. (1984). Two dopamine receptors: Biochemistry, Physiology and pharmacology. Life Sci., 35, 2281-2296
DOI
ScienceOn
|
27 |
Hardman, J. G., Limbird, L. E., Molinoff P. B., Ruddon, R. W. Gilman, A. G. (1996). Goodman & Gilman's The Phar-macological Basis of Therapeutics. 9th ed. McGraw Hill, International Edition, pp. 282-283
|
28 |
Hytell, J. (1983). SCH 23390-The first selective dopamine antagonisl. J. Parmacol, 91, 153-157
DOI
ScienceOn
|
29 |
lorio, L. C., Barnett, A., Leitz, F. H., Houser, V. P., Korduba, C. A. (1983). SCH 23390, a potential benzazepine antipsy-chotic with unique interactions on doparninergic systems. J. Pharmacol. Exp. Ther., 226, 462-468
|
30 |
Jtoh, Y., Beaulieu, M. and Kebabian, J. W. (1984). The chemical basis for the blockade of the D, dopamine receptor by SCH 23390. Eur. J. Pharmacol., 100, 119-124
DOI
ScienceOn
|
31 |
Sidhu, A., van Ocne, J. C., Dandrige, P,, Kaiser, C., Kebabian, J. W. (1986). [125-1] SCH 23390: The ligand of choice for idenlifying the dopamine receptor. Eur. Pharmacol., 128, 213-217
DOI
ScienceOn
|
32 |
Pitts, R. F. (1968). Physiology of the Kidney and Body Fluids, Chicago: Year Book Medical Pubulishers, Inc., p.150
|
33 |
Romero, J. C,, Lahera, V, Salom, M. G. and Binondi, M. L. (1992). Role of the endo-thelium-dependent relaxing factor nitric oxide on renal function. J. Am, Soc, Nephron., 2, 1371-1387
|
34 |
Seeman, P. (1981). Brain dopamine receptors. Pharmacol. Rev., 32, 229-313
|
35 |
Slick, G. L., Agilera, A. J., Zambrack, E. J., DiBona, G. F. and Kaloyanides, G. F. (1975). Renal neuroadrenergic transmi-sion. Am. J. Physiol, 229, 60-68
|